Literature DB >> 12443002

Asthma: the psychosocial impact among a sample of south western Nigerians.

Gregory E Erhabor1, Folake Kuteyi, Femi Obembe.   

Abstract

Morbidity and mortality from asthma continues to increase worldwide. Investigations conducted in Western countries have shown that psychiatric morbidity may play a role in increasing mortality due to asthma. However, the association between psychopathology and asthma has not been fully investigated among Nigerian patients. 50 asthmatics seen in the Chest Clinic of the Obafemi Awolowo University Teaching Hospital Complex (OAUTCH), Ile-Ife, were examined using the 30-item general health questionnaire (GHQ-30). A control group of 48 Nigerians with a similar socio-demographic background were also studied. A significantly higher prevalence of psychiatric disorder (50%) were found in the asthmatic group, while only 27.1% of the control group had psychopathology. Twenty-one (87.5%) of the asthmatics with frequent attacks had psychopathology compared to only four (25%) with less frequent attacks. Psychiatric morbidity did not show any relationship to the level of educational attainment or other socio-demographic variables. This result suggests a high prevalence of psychiatric morbidity among Nigerian asthmatics. The management of asthma should take a wholistic approach: physical, as well as the psychosocial factors should be considered.

Entities:  

Mesh:

Year:  2002        PMID: 12443002      PMCID: PMC2594181     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  19 in total

1.  Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A Ketelaars; M A Schlösser; R Mostert; H Huyer Abu-Saad; R J Halfens; E F Wouters
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  Use of the general health questionnaire in clinical work.

Authors:  D Goldberg
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

3.  Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study.

Authors:  P M Yellowlees; S Haynes; N Potts; R E Ruffin
Journal:  Med J Aust       Date:  1988-09-05       Impact factor: 7.738

4.  Psychiatric and social aspects of brittle asthma.

Authors:  G M Garden; J G Ayres
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

5.  Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital.

Authors:  H S Aghanwa; G E Erhabor
Journal:  J Psychosom Res       Date:  2001-04       Impact factor: 3.006

6.  Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders.

Authors:  J E Wells; J A Bushnell; A R Hornblow; P R Joyce; M A Oakley-Browne
Journal:  Aust N Z J Psychiatry       Date:  1989-09       Impact factor: 5.744

7.  One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

Authors:  D A Regier; J H Boyd; J D Burke; D S Rae; J K Myers; M Kramer; L N Robins; L K George; M Karno; B Z Locke
Journal:  Arch Gen Psychiatry       Date:  1988-11

8.  International trends in asthma mortality: 1970 to 1985.

Authors:  R Jackson; M R Sears; R Beaglehole; H H Rea
Journal:  Chest       Date:  1988-11       Impact factor: 9.410

9.  A comparison of asthma deaths and near-fatal asthma attacks in South Australia.

Authors:  D A Campbell; G McLennan; J R Coates; P A Frith; P A Gluyas; K M Latimer; C G Luke; A J Martin; D M Roder; R E Ruffin
Journal:  Eur Respir J       Date:  1994-03       Impact factor: 16.671

10.  A case-control study of deaths from asthma.

Authors:  H H Rea; R Scragg; R Jackson; R Beaglehole; J Fenwick; D C Sutherland
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

View more
  1 in total

Review 1.  The vital link between chronic disease and depressive disorders.

Authors:  Daniel P Chapman; Geraldine S Perry; Tara W Strine
Journal:  Prev Chronic Dis       Date:  2004-12-15       Impact factor: 2.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.